Home/Filings/4/0001209191-18-036428
4//SEC Filing

MacPhee John A 4

Accession 0001209191-18-036428

CIK 0001328143other

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 5:11 PM ET

Size

5.5 KB

Accession

0001209191-18-036428

Insider Transaction Report

Form 4
Period: 2018-06-06
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-06-06+10,00010,000 total
    Exercise: $27.98Exp: 2028-06-05Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]The Option shares shall vest as follows: 100% of the option shares shall vest on the date 1 year from June 6, 2018, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of such date.

Issuer

Adamas Pharmaceuticals Inc

CIK 0001328143

Entity typeother

Related Parties

1
  • filerCIK 0001339976

Filing Metadata

Form type
4
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 5:11 PM ET
Size
5.5 KB